ViaLase Completes Enrollment for the Pivotal VIA-002 Trial of the ViaLase® Laser to Treat Primary Open Angle Glaucoma
ViaLase, Inc., a clinical-stage medical technology company focused on addressing unmet needs in the conventional glaucoma…
Arboretum_JDOctober 31, 2023